About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
PIRS - Pieris Pharmaceutica...| Previous Close | $2.03 | Open | $2.02 |
| Volume | 783.3K | Market Cap | 106.37M |
| Yield | Last Dividend |
| Recap: Pieris Pharmaceuticals Q2 Earning... | 08/10/20 |
| Shares of Pieris Pharmaceuticals (NASDAQ:PIRS) rose 8% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per sha... | |
| Pieris Pharmaceuticals : to Host Second ... | 08/03/20 |
| Pieris Pharmaceuticals to Host Second Quarter 2020 Investor Call and Corporate Update on August 10, 2020 Download PDF BOSTON, MA / ACCESSWIRE / August... | |
| Pieris Pharmaceuticals (PIRS) May Report... | 05/01/20 |
| Pieris Pharmaceuticals (PIRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get ... | |
| Pieris Pharmaceuticals : Reports Full-Ye... | 03/12/20 |
| COMPANY TO HOST AN INVESTOR CONFERENCE CALL ON THURSDAY, MARCH 12, 2020 AT 8:00 AM EDT BOSTON, MA / ACCESSWIRE / March 12, 2020 /Pieris Pharmaceutical... | |
| The Daily Biotech Pulse: NY State Endors... | 03/11/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10)... | |
| Pieris Pharmaceuticals : Announces Leade... | 01/08/20 |
| BOSTON, MA / ACCESSWIRE / January 8, 2020 / Pieris Pharmaceuticals, Inc. , a clinical-stage biotechnology company advancing novel biotherapeutics thro... | |
| Pieris Pharmaceuticals (NASDAQ:PIRS) Ann... | 11/14/19 |
| Pieris Pharmaceuticals (NASDAQ:PIRS) issued its quarterly earnings results on Monday. The biotechnology company reported ($0.05) earnings per share fo... | |
| Pieris Pharmaceuticals : to Host R&D Eve... | 11/07/19 |
| BOSTON, MA / ACCESSWIRE / November 7, 2019 / Pieris Pharmaceuticals, Inc. , a clinical-stage biotechnology company advancing novel biotherapeutics thr... | |
| 3 Names Making the Case That Investing i... | 11/06/19 |
| Karyopharm Therapeutics (KPTI), Pieris Pharmaceuticals (PIRS) and Supernus Pharmaceuticals (SUPN) are making the case this week that investing in smal... | |
| Pieris Pharmaceuticals : Announces $32 M... | 11/04/19 |
| BOSTON, MA / ACCESSWIRE / November 4, 2019 / Pieris Pharmaceuticals, Inc. , a clinical-stage biotechnology company advancing novel biotherapeutics thr... | |
| Pieris Pharmaceuticals : to Host Third Q... | 11/04/19 |
| BOSTON, MA / ACCESSWIRE / November 4, 2019 / Pieris Pharmaceuticals, Inc. , a clinical-stage biotechnology company advancing novel biotherapeutics thr... | |
| The Week Ahead In Biotech: Smid-Cap Earn... | 11/03/19 |
| Biotech stocks extended their gains last week amid earnings news flow and the broader market strength. Large-cap pharma stocks saw particular strength... | |
| Do Institutions Own Shares In Pieris Pha... | 07/11/19 |
| The big shareholder groups in Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) have power over the company. Institutions??? | |
| These 4 Charts Are Looking Better And Be... | 06/12/19 |
| Here are four stocks that appear to be at or near a breakout point: Enphase Energy, Inc . (NASDAQ: ENPH ) jumped 88 cents to $17.07 on 4 million share... | |
| FL, TSS, CVCO and IMRN among midday move... | 05/24/19 |
| No summary available. | |
| Aphria and Biocept among healthcare gain... | 05/24/19 |
| No summary available. | |
| BTIG likes MannKind in premarket analyst... | 05/14/19 |
| No summary available. | |
| Pieris Pharmaceuticals: Cash-Rich, Key R... | 05/14/19 |
| No summary available. | |
| Pieris Pharmaceuticals, Inc. (PIRS) CEO ... | 05/10/19 |
| No summary available. | |
| Pieris Pharma Q1 top line up 102% | 05/10/19 |
| No summary available. | |
| Pieris Pharmaceuticals misses by $0.02, ... | 05/10/19 |
| No summary available. | |
| Analysts Estimate Pieris Pharmaceuticals... | 05/02/19 |
| Pieris Pharmaceuticals (PIRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get ... | |
| Bicycle Therapeutics IPO: A Nobel Laurea... | 05/02/19 |
| No summary available. | |
| Bicycle Therapeutics Files For U.S. IPO | 04/29/19 |
| No summary available. | |
| Pieris Pharmaceuticals, Inc. (PIRS) CEO ... | 03/12/19 |
| No summary available. | |
| January Barometer Shows Momentum And For... | 01/31/19 |
| No summary available. | |
| January Barometer Shows Momentum And For... | 01/31/19 |
| No summary available. | |
| Spectrum Of Momentum Stocks Dominating T... | 01/11/19 |
| No summary available. | |
| Spectrum Of Momentum Stocks Dominating T... | 01/11/19 |
| No summary available. | |
| Biotechs up out the gate on Lilly/Loxo t... | 01/07/19 |
| No summary available. | |
| Date | 2020-08-10 (BMO) | Est. (EPS/Rev.) | ($0.17)/ 7.76M |
| Actual (EPS/Rev.) | $-0.09/ $11.25 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Trading Systems | Trading Systems | 83.00 % | Subscribe |
| Mojo Day Trading | ProTrader Mike | 46.00 % | Subscribe |
| Option Ripper | Option Ripper | 34.00 % | Follow |
| cerevisiology | John Cho | 19.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
